Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.

BACKGROUND: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, e...

Full description

Bibliographic Details
Main Authors: Xin-Yuan Zhu, Pei Li, Ya-Bing Yang, Mei-Lin Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3651163?pdf=render
id doaj-d7f68b43b234453e82b50e4a84c9e4e9
record_format Article
spelling doaj-d7f68b43b234453e82b50e4a84c9e4e92020-11-25T01:29:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6273110.1371/journal.pone.0062731Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.Xin-Yuan ZhuPei LiYa-Bing YangMei-Lin LiuBACKGROUND: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. METHODOLOGY/PRINCIPAL FINDINGS: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD +Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. CONCLUSIONS/SIGNIFICANCE: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.http://europepmc.org/articles/PMC3651163?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Xin-Yuan Zhu
Pei Li
Ya-Bing Yang
Mei-Lin Liu
spellingShingle Xin-Yuan Zhu
Pei Li
Ya-Bing Yang
Mei-Lin Liu
Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.
PLoS ONE
author_facet Xin-Yuan Zhu
Pei Li
Ya-Bing Yang
Mei-Lin Liu
author_sort Xin-Yuan Zhu
title Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.
title_short Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.
title_full Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.
title_fullStr Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.
title_full_unstemmed Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats.
title_sort xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased enos expression in atherosclerotic rats.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: Xuezhikang is the extract of red yeast rice, which has been widely used for the management of atherosclerotic disease, but the molecular basis of its antiatherosclerotic effects has not yet been fully identified. Here we investigated the changes of eNOS in vascular endothelia and RBCs, eNOS regulatory factor Caveolin-1 in endothelia, and hemorheological parameters in atherosclerotic rats to explore the protective effects of Xuezhikang. METHODOLOGY/PRINCIPAL FINDINGS: Wistar rats were divided into 4 groups (n = 12/group) group C, controls; group M, high-cholesterol diet (HCD) induced atherosclerotic models; group X, HCD+Xuezhikang; and group L, HCD +Lovastatin. In group X, Xuezhikang inhibited oxidative stress, down-regulated caveolin-1 in aorta wall (P<0.05), up-regulated eNOS expression in vascular endothelia and erythrocytes (P<0.05), increased NOx (nitrite and nitrate) in plasma and cGMP in erythrocyte plasma and aorta wall (P<0.05), increased erythrocyte deformation index (EDI), and decreased whole blood viscosity and plasma viscosity (P<0.05), with the improvement of arterial pathology. CONCLUSIONS/SIGNIFICANCE: Xuezhikang up-regulated eNOS expression in vascular endothelia and RBCs, increased plasma NOx and improved abnormal hemorheology in high cholesterol diet induced atherosclerotic rats. The elevated eNOS/NO and improved hemorheology may be beneficial to atherosclerotic disease.
url http://europepmc.org/articles/PMC3651163?pdf=render
work_keys_str_mv AT xinyuanzhu xuezhikangextractofredyeastriceimprovedabnormalhemorheologysuppressedcaveolin1andincreasedenosexpressioninatheroscleroticrats
AT peili xuezhikangextractofredyeastriceimprovedabnormalhemorheologysuppressedcaveolin1andincreasedenosexpressioninatheroscleroticrats
AT yabingyang xuezhikangextractofredyeastriceimprovedabnormalhemorheologysuppressedcaveolin1andincreasedenosexpressioninatheroscleroticrats
AT meilinliu xuezhikangextractofredyeastriceimprovedabnormalhemorheologysuppressedcaveolin1andincreasedenosexpressioninatheroscleroticrats
_version_ 1725097949081370624